← Evidence map

ArticleNeuro-oncology2021

Especially for neuro-oncologists-minimally important differences for the EORTC QLQ-C30 in glioma patients.

Tito R MendozaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 34036365